The Product Stewardship Institute’s Scott Cassel and Vivian Fuhrman recently submitted the following letter to the editor to the New York Times in response to its November 4th article, Opioid Poisonings Rise Sharply Among Toddlers and Teenagers.
In the October 31st article, “Opioid Poisonings Rise Sharply Among Toddlers and Teenagers,” you fail to mention drug take-back as the best option for families to rid their homes of the over 1 billion dollars in leftover drugs that sit in medicine cabinets and become a gateway to addiction, abuse, and accidental poisonings. Massachusetts, Vermont, and 14 counties or cities in California, Illinois, and Washington passed laws that make pharmaceutical companies responsible for financing and/or managing jurisdiction-wide drug take-back programs designed to provide residents with convenient, safe drop-off locations at pharmacies, hospitals, and law enforcement agencies. Many countries in Canada and Europe also have laws that require industry to manage the proper disposal of the medications they put into the marketplace. Unfortunately, U.S. pharmaceutical companies continue to promote garbage disposal and refuse to take responsibility for safe drug disposal. It’s time for the American pharmaceutical industry to be held accountable for the massive quantities of leftover medicines that contribute to the opioid epidemic, which has torn apart families and imposed unacceptable health costs on society.
Scott Cassel, CEO/Founder
Vivian Fuhrman, Ph.D., Associate for Policy and Programs